Torrey Pines Stem Cell Series is categorized under Noncommercial Biotechnical Research in La Jolla, CA and active since 2007.
Torrey Pines Stem Cell Series was established in 2007, and today employs 1 to 4, earning $0 to $49.999 per year. This is a Noncommercial Biotechnical Research business, which does work in the B2B market, and is classified as a Noncommercial Biotechnical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Norman Palmer at the company’s single location by writing to 5580 La Jolla Boulevard # 319, La Jolla, California CA 92037 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Torrey Pines Stem Cell Series |
| Contact Person: | Norman Palmer |
| Address: | 5580 La Jolla Boulevard # 319, La Jolla, California 92037 |
| Annual Revenue (USD): | $0 to $49.999 |
| Founded: | 2007 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Noncommercial Biotechnical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Torrey Pines Stem Cell Series was started in 2007 to provide professional Noncommercial Biotechnical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $0 to $49.999 per annum.
Feel free to contact Norman Palmer for inquiries that concern Torrey Pines Stem Cell Series by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Torrey Pines Stem Cell Series can be found at the coordinates 32.813541,-117.269574 as well as the street address 5580 La Jolla Boulevard # 319 in La Jolla, California 92037.
For its online presence, you may visit Torrey Pines Stem Cell Series’s website at and engage with its social media outlets through on Twitter and on Facebook.